ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

In Brief: FDA Changes Package Inserts For Thiotepa, Cyclophosphamide, As Committee Suggested

August 31, 1979

Kramer Says New Radiotherapy Could Save 1.3 Of Failures

February 18, 1977

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Nobel Physicist Calls For Doubling Of Science Budget

January 11, 1991